There is a growing clinical and scientific interest in catheter-directed therapy (CDT) of acute
pulmonary embolism (PE). Currently, CDT should be considered for patients with high-risk …

Cancer-associated venous thromboembolism (VTE) is a leading cause of morbidity and
mortality in patients with cancer. Appropriate risk stratification for primary and secondary …

Background Pulmonary embolism (PE) is a common life‐threatening cardiovascular
condition, with an incidence of 23 to 69 new cases per 100,000 people each year. For …

Pulmonary embolism is a frequent and potentially fatal disease. The major challenge of
initial management lies in prognostic stratification. Since 2014, the European …

Rationale and Objectives Acute pulmonary embolism (APE) is a common disease with a
high mortality, especially in the short term. Computed tomographic pulmonary angiography …

Objective: To document the association between serum transaminases and in-hospital
mortality in pulmonary embolism (PE) patients. Study Design: Analytical study. Place and …

Introduction Pulmonary embolism (PE) is a life-threatening disease. Risk stratification in
patients with acute PE can guide clinical decisions. Clinical assessment, including …

Background: Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is
associated with poor prognosis in cardiovascular diseases. However, the predictive value of …

Acute pulmonary embolism (APE) is a significant cause of mortality. While numerous studies
have tried to improve its prognostic evaluation, the risk stratification remains challenging [1] …

Ischaemic heart disease remains the leading cause of mortality worldwide and, whilst there
has been progress in reducing this, mainly due to smoking cessation, there are concerns …